jueves, 1 de noviembre de 2018

Schedule a Meeting Today | Visit Catalent Experts at AAPS: Booth #1727

.Com Header
Join Catalent at AAPS to Debate
Latest Applied Development Approaches
We have the passion to unlock the potential of your small and large molecules. With expanded early development solutions, and the acquisition of Juniper Pharmaceuticals. Catalent has you covered from candidate selection to commercialization.
Visit us at booth 1727 to November 4-7 to debate, discover and learn more about new approaches, latest technologies and best practices in drug development
 
  • Four presentation 
  • Six research posters
  • In-booth networking reception
  • Pharma consultant breakfast session
  • Catalent experts available during AAPS community socials
 
Schedule a meeting with our experts during the event.
 
Schedule a Meeting
Check Out our Networking Opportunities
Don’t Miss our Networking Reception
on November 5
 
Join us on Monday, November  5th, at booth 1727 from 3:30 – 5 p.m. to network with Catalent experts and industry colleagues, enjoy refreshments, and dive deeper into the topics being discussed with our experts.
Learn More
Pharma Consultant Breakfast Session
on November 6
 
Hear from experienced industry colleagues on the latest tips that will help your clients avoid critical pitfalls, and leverage CDMO experts. Enjoy a complimentary breakfast minutes away from the exhibit hall. Limited availability.
Register Today
Hear Leading Catalent & Industry Experts
on the Latest Trends
Monday, November 5th Sessions
  • 9:30 a.m., “Automated Solutions for Non-GMP/GMP Bioassays for Biological Drug Development, Now and Future State”.  Jeff Dixon, Principal Scientist, Catalent, will explain the benefits of assay automation and explore its future direction.
    • 2 p.m., “Cutting Edge Analytical Techniques to Expedite Drug Development”.Ronak Savla, Pharm.D., Ph.D., Scientific Affairs Manager, will moderate the panel session on latest analytical approaches for accelerating development.
 
Tuesday, November 6th Sessions
  • 10:30 a.m., “Does the DCS System Really Work in Determining the Most Effective Formulation Strategy?”, industry experts will debate the effectiveness of the DCS, questioning its usefulness in identifying bioavailability issues and will use case studies to illustrate the merits of DCS evaluation. hosted by Stephen Tindal, Director, Science & Technology, Catalent
  • 3:30 p.m., “Patient-Focused Drug Design – a View from the R&D Front Lines”. Cornell Stamoran, Ph.D., Vice President of Strategy and Co-Chair of the Catalent Applied Drug Delivery Institute, will lead a discussion on creating better treatments for patients through better drug design.

Learn More
Schedule a Meeting
Debate & Challenge our Experts
Challenge us and meet Catalent Scientists and other industry experts for a free consultation over refreshments during and after the NEW AAPS community Social Hours at the HUB and Catalent booth next to it! Experts will be on hand to continue the conversation and discuss how Catalent approaches each Community Social topic.
 
For full details on the event click here to view the full agenda.
 
View Agenda
Latest Research on Drug Development Challenges

No hay comentarios:

Publicar un comentario